1. Home
  2. BNBX vs MTNB Comparison

BNBX vs MTNB Comparison

Compare BNBX & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BNBX

Applied DNA Sciences Inc.

N/A

Current Price

$0.64

Market Cap

3.6M

ML Signal

N/A

Logo Matinas Biopharma Holdings Inc.

MTNB

Matinas Biopharma Holdings Inc.

HOLD

Current Price

$0.51

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNBX
MTNB
Founded
1983
2013
Country
United States
United States
Employees
26
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.9M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
BNBX
MTNB
Price
$0.64
$0.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
40.8K
14.8K
Earning Date
05-14-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
59.84
EPS
N/A
N/A
Revenue
N/A
$119,750.00
Revenue This Year
$253.12
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.61
$0.47
52 Week High
$6.17
$3.09

Technical Indicators

Market Signals
Indicator
BNBX
MTNB
Relative Strength Index (RSI) 31.01 36.09
Support Level $0.61 N/A
Resistance Level $0.85 $0.65
Average True Range (ATR) 0.06 0.06
MACD 0.00 -0.01
Stochastic Oscillator 3.59 15.76

Price Performance

Historical Comparison
BNBX
MTNB

About BNBX Applied DNA Sciences Inc.

BNB Plus Corp focuses on digital asset treasury management of BNB. The group is unlocking institutional-grade access to the Binance ecosystem, delivering non-directional yield strategies and long BNB exposure, powering the future of blockchain through a transparent, actively managed BNB treasury. The Company's differentiated blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space.

About MTNB Matinas Biopharma Holdings Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Share on Social Networks: